世界の希少神経疾患治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Rare Neurological Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4940
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、希少神経疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、有機化合物）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・希少神経疾患治療の市場動向
・企業の競争状況、市場シェア
・希少神経疾患治療の種類別市場規模（生物製剤、有機化合物）
・希少神経疾患治療の用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）
・希少神経疾患治療の北米市場規模2016-2027（アメリカ、カナダ）
・希少神経疾患治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・希少神経疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・希少神経疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・希少神経疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Allergan、Novartis、Bayer Aktiengesellschaft、Medtronic、Sanofi、Johnson & Johnson、Teva Pharmaceutical）
・結論

Market Analysis and Insights: Global Rare Neurological Disease Treatment Market
The global Rare Neurological Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rare Neurological Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rare Neurological Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rare Neurological Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rare Neurological Disease Treatment market.

Global Rare Neurological Disease Treatment Scope and Market Size
Rare Neurological Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rare Neurological Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biologics
Organic Compounds

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Allergan
Novartis
Bayer Aktiengesellschaft
Medtronic
Sanofi
Johnson & Johnson
Teva Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Neurological Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biologics
1.2.3 Organic Compounds
1.3 Market by Application
1.3.1 Global Rare Neurological Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Rare Neurological Disease Treatment Market Perspective (2016-2027)
2.2 Rare Neurological Disease Treatment Growth Trends by Regions
2.2.1 Rare Neurological Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rare Neurological Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Rare Neurological Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Rare Neurological Disease Treatment Industry Dynamic
2.3.1 Rare Neurological Disease Treatment Market Trends
2.3.2 Rare Neurological Disease Treatment Market Drivers
2.3.3 Rare Neurological Disease Treatment Market Challenges
2.3.4 Rare Neurological Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Rare Neurological Disease Treatment Players by Revenue
3.1.1 Global Top Rare Neurological Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Rare Neurological Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Rare Neurological Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rare Neurological Disease Treatment Revenue
3.4 Global Rare Neurological Disease Treatment Market Concentration Ratio
3.4.1 Global Rare Neurological Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Neurological Disease Treatment Revenue in 2020
3.5 Rare Neurological Disease Treatment Key Players Head office and Area Served
3.6 Key Players Rare Neurological Disease Treatment Product Solution and Service
3.7 Date of Enter into Rare Neurological Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Rare Neurological Disease Treatment Breakdown Data by Type
4.1 Global Rare Neurological Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Rare Neurological Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Rare Neurological Disease Treatment Breakdown Data by Application
5.1 Global Rare Neurological Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Rare Neurological Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Rare Neurological Disease Treatment Market Size (2016-2027)
6.2 North America Rare Neurological Disease Treatment Market Size by Type
6.2.1 North America Rare Neurological Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Rare Neurological Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Rare Neurological Disease Treatment Market Size by Type (2016-2027)
6.3 North America Rare Neurological Disease Treatment Market Size by Application
6.3.1 North America Rare Neurological Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Rare Neurological Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Rare Neurological Disease Treatment Market Size by Application (2016-2027)
6.4 North America Rare Neurological Disease Treatment Market Size by Country
6.4.1 North America Rare Neurological Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Rare Neurological Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Rare Neurological Disease Treatment Market Size (2016-2027)
7.2 Europe Rare Neurological Disease Treatment Market Size by Type
7.2.1 Europe Rare Neurological Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Rare Neurological Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Rare Neurological Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Rare Neurological Disease Treatment Market Size by Application
7.3.1 Europe Rare Neurological Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Rare Neurological Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Rare Neurological Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Rare Neurological Disease Treatment Market Size by Country
7.4.1 Europe Rare Neurological Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Rare Neurological Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Rare Neurological Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Rare Neurological Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Rare Neurological Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rare Neurological Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rare Neurological Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Rare Neurological Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Rare Neurological Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rare Neurological Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rare Neurological Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Rare Neurological Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Rare Neurological Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rare Neurological Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Rare Neurological Disease Treatment Market Size (2016-2027)
9.2 Latin America Rare Neurological Disease Treatment Market Size by Type
9.2.1 Latin America Rare Neurological Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Rare Neurological Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Rare Neurological Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Rare Neurological Disease Treatment Market Size by Application
9.3.1 Latin America Rare Neurological Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Rare Neurological Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Rare Neurological Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Rare Neurological Disease Treatment Market Size by Country
9.4.1 Latin America Rare Neurological Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Rare Neurological Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Rare Neurological Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Rare Neurological Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Rare Neurological Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rare Neurological Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rare Neurological Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Rare Neurological Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Rare Neurological Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rare Neurological Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rare Neurological Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Rare Neurological Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Rare Neurological Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rare Neurological Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Rare Neurological Disease Treatment Introduction
11.1.4 Pfizer Revenue in Rare Neurological Disease Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Rare Neurological Disease Treatment Introduction
11.2.4 Allergan Revenue in Rare Neurological Disease Treatment Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Rare Neurological Disease Treatment Introduction
11.3.4 Novartis Revenue in Rare Neurological Disease Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Bayer Aktiengesellschaft
11.4.1 Bayer Aktiengesellschaft Company Details
11.4.2 Bayer Aktiengesellschaft Business Overview
11.4.3 Bayer Aktiengesellschaft Rare Neurological Disease Treatment Introduction
11.4.4 Bayer Aktiengesellschaft Revenue in Rare Neurological Disease Treatment Business (2016-2021)
11.4.5 Bayer Aktiengesellschaft Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Rare Neurological Disease Treatment Introduction
11.5.4 Medtronic Revenue in Rare Neurological Disease Treatment Business (2016-2021)
11.5.5 Medtronic Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Rare Neurological Disease Treatment Introduction
11.6.4 Sanofi Revenue in Rare Neurological Disease Treatment Business (2016-2021)
11.6.5 Sanofi Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Rare Neurological Disease Treatment Introduction
11.7.4 Johnson & Johnson Revenue in Rare Neurological Disease Treatment Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Rare Neurological Disease Treatment Introduction
11.8.4 Teva Pharmaceutical Revenue in Rare Neurological Disease Treatment Business (2016-2021)
11.8.5 Teva Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Rare Neurological Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biologics
Table 3. Key Players of Organic Compounds
Table 4. Global Rare Neurological Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Rare Neurological Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Rare Neurological Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Rare Neurological Disease Treatment Market Share by Regions (2016-2021)
Table 8. Global Rare Neurological Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Rare Neurological Disease Treatment Market Share by Regions (2022-2027)
Table 10. Rare Neurological Disease Treatment Market Trends
Table 11. Rare Neurological Disease Treatment Market Drivers
Table 12. Rare Neurological Disease Treatment Market Challenges
Table 13. Rare Neurological Disease Treatment Market Restraints
Table 14. Global Rare Neurological Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Rare Neurological Disease Treatment Market Share by Players (2016-2021)
Table 16. Global Top Rare Neurological Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Neurological Disease Treatment as of 2020)
Table 17. Ranking of Global Top Rare Neurological Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Rare Neurological Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Rare Neurological Disease Treatment Product Solution and Service
Table 21. Date of Enter into Rare Neurological Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rare Neurological Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Rare Neurological Disease Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Rare Neurological Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Rare Neurological Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Rare Neurological Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Rare Neurological Disease Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Rare Neurological Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Rare Neurological Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Rare Neurological Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Rare Neurological Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Rare Neurological Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Rare Neurological Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Rare Neurological Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Rare Neurological Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Rare Neurological Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Rare Neurological Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Rare Neurological Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Rare Neurological Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Rare Neurological Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Rare Neurological Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Rare Neurological Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Rare Neurological Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Rare Neurological Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Rare Neurological Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Rare Neurological Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Rare Neurological Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Rare Neurological Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Rare Neurological Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Rare Neurological Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Rare Neurological Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Rare Neurological Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Rare Neurological Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Rare Neurological Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Rare Neurological Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Rare Neurological Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Rare Neurological Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Rare Neurological Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Rare Neurological Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Rare Neurological Disease Treatment Product
Table 64. Pfizer Revenue in Rare Neurological Disease Treatment Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Allergan Company Details
Table 67. Allergan Business Overview
Table 68. Allergan Rare Neurological Disease Treatment Product
Table 69. Allergan Revenue in Rare Neurological Disease Treatment Business (2016-2021) & (US$ Million)
Table 70. Allergan Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Rare Neurological Disease Treatment Product
Table 74. Novartis Revenue in Rare Neurological Disease Treatment Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Bayer Aktiengesellschaft Company Details
Table 77. Bayer Aktiengesellschaft Business Overview
Table 78. Bayer Aktiengesellschaft Rare Neurological Disease Treatment Product
Table 79. Bayer Aktiengesellschaft Revenue in Rare Neurological Disease Treatment Business (2016-2021) & (US$ Million)
Table 80. Bayer Aktiengesellschaft Recent Development
Table 81. Medtronic Company Details
Table 82. Medtronic Business Overview
Table 83. Medtronic Rare Neurological Disease Treatment Product
Table 84. Medtronic Revenue in Rare Neurological Disease Treatment Business (2016-2021) & (US$ Million)
Table 85. Medtronic Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Rare Neurological Disease Treatment Product
Table 89. Sanofi Revenue in Rare Neurological Disease Treatment Business (2016-2021) & (US$ Million)
Table 90. Sanofi Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Rare Neurological Disease Treatment Product
Table 94. Johnson & Johnson Revenue in Rare Neurological Disease Treatment Business (2016-2021) & (US$ Million)
Table 95. Johnson & Johnson Recent Development
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Revenue in Rare Neurological Disease Treatment Business (2016-2021) & (US$ Million)
Table 99. Teva Pharmaceutical Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Neurological Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Biologics Features
Figure 3. Organic Compounds Features
Figure 4. Global Rare Neurological Disease Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Rare Neurological Disease Treatment Report Years Considered
Figure 9. Global Rare Neurological Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Rare Neurological Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Rare Neurological Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Rare Neurological Disease Treatment Market Share by Regions (2022-2027)
Figure 13. Global Rare Neurological Disease Treatment Market Share by Players in 2020
Figure 14. Global Top Rare Neurological Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Neurological Disease Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Rare Neurological Disease Treatment Revenue in 2020
Figure 16. Global Rare Neurological Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Rare Neurological Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Rare Neurological Disease Treatment Market Share by Type (2016-2027)
Figure 20. North America Rare Neurological Disease Treatment Market Share by Application (2016-2027)
Figure 21. North America Rare Neurological Disease Treatment Market Share by Country (2016-2027)
Figure 22. United States Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Rare Neurological Disease Treatment Market Share by Type (2016-2027)
Figure 26. Europe Rare Neurological Disease Treatment Market Share by Application (2016-2027)
Figure 27. Europe Rare Neurological Disease Treatment Market Share by Country (2016-2027)
Figure 28. Germany Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Rare Neurological Disease Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Rare Neurological Disease Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Rare Neurological Disease Treatment Market Share by Region (2016-2027)
Figure 38. China Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Rare Neurological Disease Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Rare Neurological Disease Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Rare Neurological Disease Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Rare Neurological Disease Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Rare Neurological Disease Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Rare Neurological Disease Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Rare Neurological Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Rare Neurological Disease Treatment Business (2016-2021)
Figure 58. Allergan Revenue Growth Rate in Rare Neurological Disease Treatment Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Rare Neurological Disease Treatment Business (2016-2021)
Figure 60. Bayer Aktiengesellschaft Revenue Growth Rate in Rare Neurological Disease Treatment Business (2016-2021)
Figure 61. Medtronic Revenue Growth Rate in Rare Neurological Disease Treatment Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Rare Neurological Disease Treatment Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Rare Neurological Disease Treatment Business (2016-2021)
Figure 64. Teva Pharmaceutical Revenue Growth Rate in Rare Neurological Disease Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の希少内分泌疾患治療市場規模・現状・予測（2021年-2027年）

Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4938 2021年4月 97Pages
QYResearch社発行の本調査資料では、希少内分泌疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、有機化合物）、用途別市場規模（病院薬局、オンライン薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の希少疾患治療市場規模・現状・予測（2021年-2027年）

Global Rare Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4937 2021年4月 134Pages
QYResearch社発行の本調査資料では、希少疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オリジネーター医薬品、ジェネリック医薬品）、用途別市場規模（病院薬局、専門薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のクラッベ病治療市場規模・現状・予測（2021年-2027年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3334 2021年4月 92Pages
QYResearch社発行の本調査資料では、クラッベ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗けいれん薬、筋弛緩薬、HSCT（造血幹細胞移植）、その他）、用途別市場規模（病院、ASC）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の髄膜炎菌性疾患治療市場規模・現状・予測（2021年-2027年）

Global Meningococcal Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3701 2021年4月 97Pages
QYResearch社発行の本調査資料では、髄膜炎菌性疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、ワクチン）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界のニューカッスル病治療市場規模・現状・予測（2021年-2027年）

Global Newcastle Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4115 2021年4月 93Pages
QYResearch社発行の本調査資料では、ニューカッスル病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（弱毒生ワクチン、不活化ワクチン、結合型ワクチン）、用途別市場規模（獣医病院、獣医クリニック、獣医研究機関、ドラッグストア、その他）、...

世界のクッシング病治療市場規模・現状・予測（2021年-2027年）

Global Cushing’s Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1677 2021年4月 93Pages
QYResearch社発行の本調査資料では、クッシング病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、エトミデート、パシレオチド）、用途別市場規模（病院薬局、小売...

世界のレイノー病治療市場規模・現状・予測（2021年-2027年）

Global Raynauds Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4942 2021年4月 90Pages
QYResearch社発行の本調査資料では、レイノー病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アセチルシステイン、アルプロスタジル、ELS-140、ネオバスカルゲン、ニトログリセリン、その他）、用途別市場規模（病院、診療所、その他）...

世界の人獣共通感染症治療市場規模・現状・予測（2021年-2027年）

Global Zoonotic Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z6111 2021年4月 96Pages
QYResearch社発行の本調査資料では、人獣共通感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ウイルス性肝炎、狂犬病、回帰熱、結核、マラリア、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の感染症治療市場規模・現状・予測（2021年-2027年）

Global Infectious Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3147 2021年4月 97Pages
QYResearch社発行の本調査資料では、感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗菌、抗真菌薬、抗ウイルス薬）、用途別市場規模（病院＆クリニック、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の急性リンパ性白血病（ALL）治療市場規模・現状・予測（2021年-2027年）

Global Acute Lymphoid Leukemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0071 2021年4月 94Pages
QYResearch社発行の本調査資料では、急性リンパ性白血病（ALL）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、放射線療法、骨髄移植、免疫療法、その他）、用途別市場規模（成人、子供）、主要地域別市場規模（北米、ア...

世界の希少内分泌疾患治療市場規模・現状・予測（2021年-2027年） The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs and the feedback loops of homeostasis that the hormones drive. The rare endocrine …
世界の希少疾患治療市場規模・現状・予測（2021年-2027年） A rare disease is any disease that affects a small percentage of the population. Most rare diseases are genetic and thus are present throughout the person's entire life, even if symptoms do not immediately appear. Market Analysis and Insights: Global Rare Disease Treatment Market The global Rare Dis…
世界のクッシング病治療市場規模・現状・予測（2021年-2027年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Bowel Disease Treatment Market The global Inflammatory Bowel Disease Treatment market size is projected to reach US$ 15660 million by 2026, from US$ 13310 million in 2019, at a CAGR of 2.3% during 2021-2026. With industry-standard accuracy in analysi…
世界の希少血液市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Rare Hematology Market The global Rare Hematology market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a bri…